GeoVax_logo_tag_Reg.jpg 

GeoVax Labs, Inc.
1900 Lake Park Drive, Suite 380
Smyrna, GA 30080

https://www.geovax.com/

You Might Also Like...

Key Points About GeoVax

Recent News Releases

GeoVax Labs, Inc. (GOVX-NASDAQ)

GeoVax Labs, Inc. (“GeoVax” or “the Company”) is a clinical-stage biotechnology company developing preventive and therapeutic human vaccines and immunotherapies against infectious diseases and cancer. The Company recently significantly expanded its clinical stage portfolio through the in-licensing of two Phase 2 products/programs within SARS-CoV-2 and Head & Neck Cancer immunotherapy. The Company’s proprietary GV-MVA-VLP™ vector vaccine technology utilizes a Modified Vaccinia Ankara (MVA) vector, a large virus capable of carrying several vaccine antigens, which are expressed as non-infectious virus-like particles (VLPs) in the individual receiving the vaccine (in vivo). VLPs mimic a natural infection, stimulating both the humoral (antibody) and cellular (T-cells) arms of the immune system to recognize, prevent, and control the target infection through durable immune responses. In addition to the GV-MVA-VLP™ technology, the recent license of the SARS-CoV-2 vaccine (GEO/COH04S1) provides the Company a complementary technology, sMVA (synthetic MVA), and the license of Gedeptin® adds the GDEPT (Gene Directed Enzyme Prodrug Therapy) technology to the GeoVax technology platform portfolio. GeoVax is capitalizing on these technologies and its vaccine/immunotherapy design expertise to address the need for a broadly effective COVID-19 vaccine. The Company is also developing vaccines against Zika virus (ZIKV), hemorrhagic fever (HF) viruses (Ebola, Sudan, Marburg, and Lassa Fever), and malaria, while also applying its MVA-VLP™ technology to cancer immunotherapy (immuno-oncology).

* The Corporate Snapshot was last updated on March 15, 2022.


 

Latest Research

GOVX_COVER_PG_10-22-2020

 

NEW REPORT

Download GeoVax Labs, Inc.  Updated Base Report 10-21-2020

 

 

 


NEW UPDATE

 

GOVX Update April 2022 Cover

NEW UPDATE 04-29-2022

 


 

GOVX Update March 2022 Cover

03-15-2022

 


Past Research

GOVX_COVER_11-17-2021

11-17-21

 


GOVX_COVER_10-04-2021

10-04-21

 


GOVX_COVER_08-16-2021

 08-16-2021

 


 

GOVX_COVER_PG_05-11-21

 05-11-2021

 


GOVX_COVER_PG_03-29-2021

 03-29-21 

 


GOVX_COVER_PG_02-16-2021

 02-16-21

 


GOVX_COVER_PG_11-11-2020

 11-11-20

 


Cover Image Update 05-28-19

 05-28-19

 


Cover Image Update 04-01-19

 04-01-2019

 


Cover Image Update 11-14-18

  11-14-2018

 


Cover Image Update 08-14-18_jpg

   08-14-2018

 


GeoVax_Update_Cover_image_03-01-18

 03-01-2018

 


GeoVax-Quarterly-Update-Image_10-18-17.png

 10-18-2017

 


GeoVax_EIO_Cover_Image_1.png

Download GeoVax Report06-15-2017


Key Points About GeoVax

Blogs: GOVX